From USFDA
Glenmark Pharmaceuticals has been granted final approval by United States Food & Drug Administration for Drospirenone and Ethinyl Estradiol Tablets USP, 3mg/ 0.03 mg, the generic version of Yasmin Tablets of Bayer Healthcare Pharmaceuticals Inc. (Bayer) and for Levonorgestrel Tablets, 1.5 mg, the generic version of Plan B One-Step Tablet of Teva Branded Pharmaceutical Product R&D Inc., for over the counter use.Powered by Capital Market - Live News